Active ingredientBufexamacCat. No. P-B132-001CAS 2438-72-4Family · Pharmaceutical analytical standards
Bufexamac
A topical non-steroidal anti-inflammatory drug, used in creams for eczema, sunburn and itching and in suppositories for haemorrhoids; in 2010 the European Medicines Agency recommended its withdrawal because of the risk of allergic contact dermatitis. This family brings together the active ingredient and pharmacopoeial impurities.
Did you know?In 2011 a chemoproteomics study found that it specifically inhibits two epigenetic enzymes, the histone deacetylases HDAC6 and HDAC10: an old skin medicine turned research tool.
Go to the active ingredient →Active ingredientBufexamacCat. No. P-B132-001CAS 2438-72-4
Pharmacopoeial impurityBufexamac EP Impurity ACat. No. P-B132-002CAS 4547-57-3
Pharmacopoeial impurityBufexamac EP Impurity BCat. No. P-B132-003CAS 29056-06-2
Pharmacopoeial impurityBufexamac EP Impurity CCat. No. P-B132-004CAS 1185726-73-1
Pharmacopoeial impurityBufexamac EP Impurity DCat. No. P-B132-005CAS 3413-59-0No product matches your search.
EDQM standards 5
The official European Pharmacopoeia standards for this family.
Reference substanceBufexamac CRSEDQM code B1156000Family BufexamacImpurityBufexamac impurity A CRSEDQM code Y0001729Family BufexamacImpurityBufexamac impurity B CRSEDQM code Y0001730Family BufexamacImpurityBufexamac impurity C CRSEDQM code Y0001731Family BufexamacImpurityBufexamac impurity D CRSEDQM code Y0001732Family BufexamacNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.